share report revenu growth well
street estim broad consum servic strength despit sequenc
instrument come light non-gaap ep much better street
estim revenu guidanc rais revenu growth
beat ep beat
remain convinc number posit long-term tailwind sequenc
demand anticip trend well continu novaseq upgrad cycl
benefit reiter ow rate rais pt
new report result revenu well
street estim pjc gross margin increas yoy
street due mix total op-ex better street
estim rise sequenti all-in non-gaap ep beat
street estim pjc fx helix tax benefit ad ep
confer call detail sequenc consum array servic
brightest spot sequenc consum grow
estim strong consum growth transit novaseq total
array yoy anticip busi remain strong due on-going
consum adopt sequenc instrument lighter check grow
yoy miss target estim place novaseq
street pjc low end project channel check importantli
manag reiter novaseq instal call new
reimburs pathway oncolog assay sever time call
support thesi could one meaning acceler clinic
sequenc growth come year
guidanc rais manag rais top line growth
on-going ep consensu given broad
strength believ guidanc achiev potenti upsid translat
take consist channel check novaseq instrument lead
upsid quarter pronounc strength came balanc offer across
differ clinic etiolog custom product class believ better
posit mani year reiter overweight rate
rais price target base unchang multipl
ep plu net cash-per-share
on-going ep
net cash-per-share
debt total capit
technolog develop competit product adopt govern fund
lead provid genet research technolog
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
thousand
updat
product revenu
sequenc
array
servic revenu
interest incom expens net
provis incom tax
revenu
product sale
sequenc
array
servic
good sold product sale
compani report piper jaffray co current disclosur inform compani locat
